<?xml version="1.0" encoding="UTF-8"?>
<Progress_Report_Checklist
><Grant_Information
><RFA_Number
>06-01</RFA_Number
><Grant_Number
>RS1-00292-1</Grant_Number
><Reporting_Period_Start
>2/1/2010</Reporting_Period_Start
><Reporting_Period_End
>7/31/2010</Reporting_Period_End
><Institution_Name
>Ludwig Institute for Cancer Research</Institution_Name
><Primary_Investigator
><Prefix
/><First_Name
>Bing</First_Name
><Middle_Name
/><Last_Name
>Ren</Last_Name
><Suffix
/><Degree
/><Institution
/><Title
/><Department
/><Email
/><Telephone_Number
/><Extension
/><Fax_Number
/></Primary_Investigator
></Grant_Information
><Reviewer_Information
><Grants_Manager
><Prefix
/><First_Name
/><Middle_Name
/><Last_Name
/><Suffix
/><Degree
/><Institution
/><Title
/><Department
/><Email
>jlam</Email
><Telephone_Number
/><Extension
/><Fax_Number
/></Grants_Manager
><Science_Officer
><Prefix
/><First_Name
/><Middle_Name
/><Last_Name
/><Suffix
/><Degree
/><Institution
/><Title
/><Department
/><Email
>kshepard</Email
><Telephone_Number
/><Extension
/><Fax_Number
/></Science_Officer
></Reviewer_Information
><Reviews
><Budget_Review
><IsRequired
/><Grant_Manager_Notes
>Financial report is not due until 10/31/10.</Grant_Manager_Notes
><Science_Officer_Notes
>Estimating that all remaining funds were used.</Science_Officer_Notes
><Grant_Manager_Approval
>1</Grant_Manager_Approval
><Science_Officer_Approval
>1</Science_Officer_Approval
><IsComplete
/></Budget_Review
><California_Supplier_Review
><IsRequired
/><Grant_Manager_Notes
>CA Suppliers: 54%</Grant_Manager_Notes
><Science_Officer_Notes
/><Grant_Manager_Approval
>1</Grant_Manager_Approval
><Science_Officer_Approval
/><IsComplete
/></California_Supplier_Review
><Key_Personnel_Review
><IsRequired
/><Grant_Manager_Notes
/><Science_Officer_Notes
/><Grant_Manager_Approval
/><Science_Officer_Approval
>1</Science_Officer_Approval
><IsComplete
/></Key_Personnel_Review
><IACUC_Assurances_Review
><IsRequired
>0</IsRequired
><Grant_Manager_Notes
/><Science_Officer_Notes
/><Grant_Manager_Approval
>1</Grant_Manager_Approval
><Science_Officer_Approval
>0</Science_Officer_Approval
><IsComplete
/></IACUC_Assurances_Review
><IRB_Assurances_Review
><IsRequired
>0</IsRequired
><Grant_Manager_Notes
>IRB approval on 3/4/10 good for 1 year, expires 3/4/11.</Grant_Manager_Notes
><Science_Officer_Notes
>IRB not required; informed consent requirement waived for thus use of hESC.</Science_Officer_Notes
><Grant_Manager_Approval
>1</Grant_Manager_Approval
><Science_Officer_Approval
>1</Science_Officer_Approval
><IsComplete
/></IRB_Assurances_Review
><SCRO_Assurances_Review
><IsRequired
>1</IsRequired
><Grant_Manager_Notes
>ECSRO expires on 4/18/11.</Grant_Manager_Notes
><Science_Officer_Notes
/><Grant_Manager_Approval
>1</Grant_Manager_Approval
><Science_Officer_Approval
>1</Science_Officer_Approval
><IsComplete
/></SCRO_Assurances_Review
><Publication_Reporting_Review
><IsRequired
>1</IsRequired
><Grant_Manager_Notes
>Disclosures submitted, should request for actual publication.</Grant_Manager_Notes
><Science_Officer_Notes
>There are 4 publications from Year 2 for which we do not have disclosure forms. These should be submitted prior to final close out:&#xD;PMID: 19295514  Heintzman et al, Nature 459, 2009 &#xD;PMID: 19829295  Lister et al, Nature 2009&#xD;PMID: 19854636  Heintzman et al, COG&amp;D 2009&#xD;PMID:  19808796 Hawkins et al, Human Molecular Genetics 2009&#xD;</Science_Officer_Notes
><Grant_Manager_Approval
>1</Grant_Manager_Approval
><Science_Officer_Approval
>1</Science_Officer_Approval
><IsComplete
/></Publication_Reporting_Review
><Invention_Licensing_Review
><IsRequired
>0</IsRequired
><Grant_Manager_Notes
/><Science_Officer_Notes
/><Grant_Manager_Approval
>0</Grant_Manager_Approval
><Science_Officer_Approval
>0</Science_Officer_Approval
><IsComplete
/></Invention_Licensing_Review
><PI_Effort_Review
><IsRequired
>0</IsRequired
><Grant_Manager_Notes
>PI's effort meets the minimum effort for RFA. </Grant_Manager_Notes
><Science_Officer_Notes
/><Grant_Manager_Approval
/><Science_Officer_Approval
>1</Science_Officer_Approval
><IsComplete
/><Total_Current_Effort
>98</Total_Current_Effort
><CIRM_Award_Effort
>11</CIRM_Award_Effort
></PI_Effort_Review
></Reviews
><Award_Conditions
><Conditions_Exist
>0</Conditions_Exist
><Conditions_Met
><Conditions_Met
/><Grants_Manager_Notes
/><Grants_Manager_Approval
>0</Grants_Manager_Approval
><Science_Officer_Notes
/><Science_Officer_Approval
>0</Science_Officer_Approval
></Conditions_Met
><New_Conditions
><New_Conditions
>0</New_Conditions
><Grants_Manager_Notes
/><Grants_Manager_Approval
>0</Grants_Manager_Approval
><Science_Officer_Notes
/><Science_Officer_Approval
>0</Science_Officer_Approval
></New_Conditions
></Award_Conditions
><Prior_Approval
><IsRequired
>0</IsRequired
><Grant_Manager_Notes
/><Science_Officer_Notes
/><Grant_Manager_Approval
>0</Grant_Manager_Approval
><Science_Officer_Approval
>0</Science_Officer_Approval
><IsComplete
/></Prior_Approval
><OtherIssues
/><Evaluation
><Overall_Rating
>Satisfactory</Overall_Rating
><Translational_Status
>No substantial change, incremental, or N/A</Translational_Status
><Executive_Summary
>Work from Years 1 and 2 led to identification of thousands of predicted promoter, insulator and enhancer elements in H1 hESC cells, several of which were functionally validated. The goal of the NCE was to provide further support for the proposed function of these elements by evaluating DNase hypersensitivity, a hallmark feature of known transcriptional regulators.  Systematic comparisons of ChIP-Seq data to DNaseI-Seq data revealed that 90% of the predicted promoters, 60% of the predicted insulators and 47% of the predicted enhancers are associated with DNAse hypersensitivity (DSH).  Further tests of the enhancer regions revealed that about 60% are associated with DSH and/or binding of specific transcription factors such as p300, Klf4, Oct4, Nanog or Sox2. The final Aim was completed and the grant is set to close. It is possible that more publications will emerge in the near future. </Executive_Summary
></Evaluation
><Strategic_Outcome
><Five_Year_Goal_1
><IsApplicable
>0</IsApplicable
><IsComplete
>1</IsComplete
><Outcomes
/><Impact_Factor
/></Five_Year_Goal_1
><Five_Year_Goal_2
><IsApplicable
>0</IsApplicable
><IsComplete
>1</IsComplete
><Outcomes
/><Impact_Factor
/></Five_Year_Goal_2
><Five_Year_Goal_3
><IsApplicable
>0</IsApplicable
><IsComplete
>1</IsComplete
><Outcomes
/><Impact_Factor
/></Five_Year_Goal_3
><Five_Year_Goal_4
><IsApplicable
>0</IsApplicable
><IsComplete
>1</IsComplete
><Outcomes
/><Impact_Factor
/></Five_Year_Goal_4
><Five_Year_Goal_5
><IsApplicable
>0</IsApplicable
><IsComplete
>1</IsComplete
><Outcomes
/><Impact_Factor
/></Five_Year_Goal_5
><Five_Year_Goal_6
><IsApplicable
>0</IsApplicable
><IsComplete
>1</IsComplete
><Outcomes
/><Impact_Factor
/></Five_Year_Goal_6
><Five_Year_Goal_8
><IsApplicable
>0</IsApplicable
><IsComplete
>1</IsComplete
><Outcomes
/><Impact_Factor
/></Five_Year_Goal_8
><Ten_Year_Goal_1
><IsApplicable
>0</IsApplicable
><IsComplete
>1</IsComplete
><Outcomes
/><Impact_Factor
/></Ten_Year_Goal_1
><Ten_Year_Goal_2
><IsApplicable
>0</IsApplicable
><IsComplete
>1</IsComplete
><Outcomes
/><Impact_Factor
/></Ten_Year_Goal_2
><Ten_Year_Goal_5
><IsApplicable
>0</IsApplicable
><IsComplete
>1</IsComplete
><Outcomes
/><Impact_Factor
/></Ten_Year_Goal_5
><Ten_Year_Goal_7
><IsApplicable
>0</IsApplicable
><IsComplete
>1</IsComplete
><Outcomes
/><Impact_Factor
/></Ten_Year_Goal_7
><Ten_Year_Goal_8
><IsApplicable
>1</IsApplicable
><IsComplete
>1</IsComplete
><Outcomes
>Characterized and profiled a genome-wide inventory of plausible gene regulatory elements that may have roles in differentiation and lineage specification of hESCs. NCE showed additional evidence via correlation to sites with DNAse hypersensitivity. A portion was published as part of a large collaborative effort.</Outcomes
><Impact_Factor
>2</Impact_Factor
></Ten_Year_Goal_8
><Ten_Year_Goal_9a
><IsApplicable
>1</IsApplicable
><IsComplete
>1</IsComplete
><Outcomes
>Characterized and profiled a genome-wide inventory of plausible gene regulatory elements that may have roles in self renewal and pluripotency of hESC. NCE showed additional evidence to correlation of sites with DNAse hypersensitivity. A portion was published as part of a large collaborative effort.</Outcomes
><Impact_Factor
>2</Impact_Factor
></Ten_Year_Goal_9a
><Ten_Year_Goal_9b
><IsApplicable
>0</IsApplicable
><IsComplete
>1</IsComplete
><Outcomes
/><Impact_Factor
/></Ten_Year_Goal_9b
><Ten_Year_Goal_10
><IsApplicable
>0</IsApplicable
><IsComplete
>1</IsComplete
><Outcomes
/><Impact_Factor
/></Ten_Year_Goal_10
><OtherOutcomes
><IsApplicable
>0</IsApplicable
><IsComplete
>1</IsComplete
><Outcomes
/><Impact_Factor
/></OtherOutcomes
></Strategic_Outcome
><IsComplete
/></Progress_Report_Checklist
>